What is the recommended management algorithm for acute kidney injury?

Acute Kidney Injury Management Algorithm

Manage AKI using the KDIGO staging system with a structured approach prioritizing identification of reversible causes, hemodynamic optimization with balanced crystalloids, immediate nephrotoxin withdrawal, and early consideration of renal replacement therapy based on urgent indications rather than creatinine thresholds alone. 1

Step 1: Diagnosis and Staging

Define AKI by any of the following criteria:

• Serum creatinine increase ≥0.3 mg/dL (26.5 μmol/L) within 48 hours, OR
• Serum creatinine increase ≥1.5 times baseline within 7 days, OR
• Urine output <0.5 mL/kg/h for 6 hours 1

Stage severity immediately:

• Stage 1: SCr 1.5-1.9× baseline OR ≥0.3 mg/dL increase OR urine output <0.5 mL/kg/h for 6-12 hours
• Stage 2: SCr 2.0-2.9× baseline OR urine output <0.5 mL/kg/h for ≥12 hours
• Stage 3: SCr ≥3.0× baseline OR SCr ≥4.0 mg/dL (with acute rise ≥0.3 mg/dL) OR initiation of RRT OR urine output <0.3 mL/kg/h for ≥24 hours OR anuria ≥12 hours 1

Critical caveat: In cirrhotic patients, use the modified KDIGO criteria which eliminate urine output criteria (unreliable due to diuretics and sodium retention) and establish baseline creatinine from values within the previous 3 months 2, 3, 4.

Step 2: Immediate Risk Stratification and Cause Identification

Classify AKI etiology systematically:

Prerenal (functional): Check for hypovolemia, hypotension, heart failure, cirrhosis, sepsis, or medications causing renal hypoperfusion (ACE-I/ARBs, NSAIDs, diuretics)

Intrinsic renal: Evaluate for nephrotoxins (aminoglycosides, contrast, chemotherapy), acute tubular necrosis from prolonged hypoperfusion, glomerulonephritis, or interstitial nephritis

Postrenal (obstructive): Perform renal ultrasonography in all patients, particularly men >50 years, to exclude obstruction 5

Essential initial workup:

• Fractional excretion of sodium (FENa <1% suggests prerenal)
• Urinalysis with microscopy (granular casts = ATN; RBC casts = glomerulonephritis; WBC casts = interstitial nephritis)
• Complete blood count
• Renal ultrasound 5

Step 3: Immediate Interventions (The AKI Bundle)

Execute these measures within the first hours:

A. Hemodynamic Optimization

• Fluid resuscitation: Use isotonic crystalloids (balanced solutions preferred over 0.9% saline to reduce risk of hyperchloremic acidosis and further kidney injury) 6
• Avoid hydroxyethyl starch - associated with increased RRT requirement and mortality 7
• Target mean arterial pressure: Use vasopressors in vasomotor shock to maintain adequate perfusion pressure 6
• Monitor for fluid overload: Avoid automatic fluid loading in response to oliguria; assess cardiac output, CVP, right ventricular function, and intra-abdominal pressure 8

B. Nephrotoxin Elimination

Immediately discontinue or avoid:

• NSAIDs
• Aminoglycosides
• ACE inhibitors/ARBs (hold temporarily, reassess for reinitiation after recovery) 6
• Vasodilators
• Diuretics (unless managing fluid overload)
• Any non-essential nephrotoxic medications 3

C. Contrast-Associated AKI Prevention

For patients requiring contrast:

• Pre-hydrate with isotonic saline (0.9% NaCl) or sodium bicarbonate solution
• Do NOT use: N-acetylcysteine IV, prophylactic hemodialysis, or hemofiltration 1, 7
• Calculate risk using validated scores (age >75, diabetes, heart failure, baseline SCr >1.5 mg/dL, contrast volume) 9

Step 4: Stage-Specific Management

Stage 1 AKI:

• Withdraw diuretics and nephrotoxins
• Correct hypovolemia if present
• Close monitoring of SCr and urine output
• In cirrhosis: If SCr remains <1.5 mg/dL (Stage 1-A), mortality risk is similar to no AKI; if SCr ≥1.5 mg/dL (Stage 1-B), escalate management 2

Stage 2-3 AKI:

• Continue Stage 1 measures
• In cirrhosis: Administer albumin 1 g/kg for 2 days for volume expansion 3, 4
• Assess for hepatorenal syndrome criteria if cirrhotic (requires vasoconstrictors + albumin) 3
• Prepare for potential RRT

Step 5: Renal Replacement Therapy Decision-Making

Initiate RRT based on urgent indications, NOT creatinine alone:

Absolute Indications (Initiate Immediately):

• Refractory hyperkalemia
• Severe metabolic acidosis (intractable)
• Volume overload unresponsive to diuretics
• Uremic complications (encephalopathy, pericarditis, pleuritis)
• Certain toxin removal 5

Trajectory-Based Initiation:

Consider early RRT when:

• Progressive oliguria/anuria despite optimization
• Rapidly rising creatinine with no response to conservative measures
• Fluid overload with hemodynamic compromise
• Clinical deterioration despite AKI bundle implementation 10, 8

The timing debate: Current evidence does not support routine "early" initiation based solely on biomarkers or mild creatinine elevations. Use individualized strategy integrating AKI trajectory, etiology, comorbidities, and response to conservative measures 10

RRT Modality Selection:

• Continuous RRT (CRRT): Preferred for hemodynamically unstable patients 1, 7
• Intermittent hemodialysis: Acceptable for stable patients
• Dosing targets: Kt/V of 3.9/week for intermittent RRT; effluent volume 20-25 mL/kg/h for CRRT 1
• Anticoagulation: Use regional citrate or heparin (avoid heparin in HIT) 1
• Buffer: Use bicarbonate rather than lactate, especially in shock or liver failure 1

Step 6: RRT Discontinuation Criteria

Stop RRT when at least 2 of the following are met:

• Urine output >400 mL/day without diuretics OR >2000 mL/day with diuretics
• Creatinine clearance ≥15 mL/min
• Low/declining biomarker levels
• Clinical stability with resolution of indication for RRT 10

Common pitfall: Premature discontinuation leads to RRT reinitiation. Ensure sustained improvement over 24-48 hours before stopping.

Step 7: Post-AKI Follow-Up

Evaluate all patients 3 months after AKI episode:

• Assess for resolution, new-onset CKD, or worsening of pre-existing CKD
• If CKD develops (GFR <60 mL/min/1.73m² >3 months), manage per CKD guidelines
• If no CKD, consider patient at increased risk and provide preventive counseling 1

Long-term implications: AKI survivors have increased risk of CKD progression, cardiovascular events, and mortality even after apparent recovery 1.

Critical Pitfalls to Avoid

1. Do not rely on creatinine alone in cirrhosis, sarcopenia, or fluid overload - consider cystatin C when creatinine is unreliable 8
2. Do not automatically fluid load oliguria - assess hemodynamics and venous congestion first 8
3. Do not use 0.9% saline exclusively - balanced crystalloids reduce kidney injury risk 6
4. Do not delay RRT when urgent indications present - mortality increases with delayed intervention in life-threatening complications
5. Do not forget drug dosing adjustments - renally cleared medications require dose reduction based on GFR